|
Neurological diseases | lncRNA | Main target gene | Expression | Mechanism | Function | Models | Ref. |
|
Alzheimer’s disease | 17A | GABABR2 | Up | 17A downregulation promotes autophagy by elevating GABABR2 expression | Inducing Aβ secretion and increment of the Aβ42/40 ratio | SH-SY5Y cells treated with amyloid β peptide1-42 | [41, 42] |
NEAT1 | NEDD4L and PINK1 | Up | Inhibiting PINK1-independent mitophagy by promoting NEDD4L-mediated PINK1 ubiquitination and degradation | Increasing Aβ accumulation | APP/PS1 mice | [46] |
Parkinson’s disease | NEAT1 | PINK1 | Up | Promoting autophagy through stabilizing PINK1 protein | Alleviating dopaminergic neuronal injury | MPTP mouse model and MPP+-induced SH-SY5Y | [51] |
SNHG1 | miR-221/222 | Up | SNHG1 downregulation increased LC3-II levels through the miR-221/222/p27/mTOR pathway | Enhancing α-synuclein aggregation thus leads to dopaminergic toxicity | MPTP mouse model and MPP+-induced MN9D cells | [56] |
HOTAIR | LRRK2 | Up | Promoting autophagy by improving LRRK2 mRNA stability and activating ERK/MAPK pathways | Increasing the loss of striatal dopamine and promoting PD progression | MPTP mouse model and MPP+-induced SH-SY5Y | [57] |
miR-126-5p | Suppressing autophagy trough HOTAIR/miR-126-5p/RAB3IP axis | Elevating the loss of striatal dopamine and the accumulation of α-synuclein | MPTP rat model and MPP+-induced SH-SY5Y | [59] |
HAGLROS | miR-100 | Up | Inhibiting autophagy via regulating miR-100/ATG10 axis and PI3K/AKT/mTOR pathway activation | Contributing to the development of PD | MPTP mouse model and MPP+-induced SH-SY5Y | [61] |
Ischemic stroke | H19 | DUSP5 | Up | Promoting autophagy through regulating DUSP5-ERK1/2 axis | Aggravating cerebral ischemia-reperfusion injury | SH-SY5Y cell culture | [71] |
SNHG12 | Unknown | Up | Activating beclin1-dependent autophagy | Alleviating cerebral ischemia-reperfusion injury | SH-SY5Y cell culture | [76] |
MALAT1 | miR-26b | Up | Activating autophagy through upregulation of ULK2 | Attenuating ischemia-reperfusion injury | BMEC culture | [74] |
miR-200c-3p | Promoting autophagy by regulating miR-200c-3p/Sirt1 axis | [75] |
miR-30a | Promoting autophagy via MALAT1/miR-30a/beclin1 axis | Aggravating ischemic injury | Mouse brain and N2a cells | [73] |
KCNQ1OT1 | miR-200a | Up | Promoting the formation of autophagosomes through the mir-200a/FOXO3/ATG7 axis | Aggravating neurological impairments | Mouse brain and SH-SY5Y cell culture | [78] |
Epilepsy | MALAT1 | PI3K/AKT | Up | Activating autophagy by inhibiting PI3K/AKT signaling pathway | Promoting the degeneration and necrosis of hippocampal neurons | Rats with EP | [81] |
Glioma | MEG3 | PI3K/AKT/mTOR | Down | Activating autophagy by downregulating of the PI3K/AKT/mTOR pathways and the upregulating of Sirt7 | Repressing cell proliferation and migration | U251 cell lines | [92] |
Unknown | Suppressing cisplatin-induced excessive autophagy | Increasing glioma cell sensitive to cisplatin | U87 cell lines | [93] |
PVT1 | miR-186 | Up | Activating autophagy through upregulation of ATG7 and Beclin1 | Promoting proliferation, migration and angiogenesis | hCMEC/D3 | [94] |
MALAT1 | miR-101 | Up | Activating autophagy through upregulation | Promoting cell proliferation | Glioma tissue from patients, U87, U118, | [96] |
STMN1, RAB5A, and ATG4D | U251, U373, and D247 cell lines |
miR-384 | Activating autophagy through upregulation GOLM1 | Enhancing glioma migration and invasion | Glioma tissue from patients, SHG-44, and LN229 cells | [100] |
GAS5 | mTOR | Up | Suppressing cisplatin-induced excessive autophagy in an mTOR-independent manner | Increasing glioma cell sensitive to cisplatin | U87 and u138 cell lines | [103] |
|